NBN c.657_661del (p.Lys219Asnfs*16), an Eastern European founder loss-of-function frameshift variant associated with increased risk for breast, prostate, colorectal, and additional cancers [32,33,34], was identified in three siblings in branch 10, who were unaffected by cancer at the close of study (Figure 1). The gene discussed is NBN; the disease is cancer.